Efficacy and tolerability of a selegiline transdermal system in patients with major depressive disorder
Phase of Trial: Phase III
Latest Information Update: 17 Oct 2012
At a glance
- Drugs Selegiline (Primary)
- Indications Major depressive disorder
- Focus Registrational; Therapeutic Use
- 17 Oct 2012 Results, including a post-hoc analysis, presented at the 25th Annual Congress of the European College of Neuropsychopharmacology.
- 05 Nov 2010 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History